ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 939 filers reported holding ASTRAZENECA PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,109 | -79.9% | 3,117 | -79.4% | 0.05% | -78.1% |
| Q1 2023 | $1,047,908 | +94562.0% | 15,097 | -7.6% | 0.22% | -9.7% |
| Q4 2022 | $1,107 | -99.9% | 16,332 | +18.3% | 0.24% | +28.0% |
| Q3 2022 | $757,000 | +4.6% | 13,805 | +26.0% | 0.19% | +7.5% |
| Q2 2022 | $724,000 | +12.9% | 10,954 | +13.4% | 0.17% | +6.8% |
| Q1 2022 | $641,000 | +28.5% | 9,659 | +12.7% | 0.16% | +29.6% |
| Q4 2021 | $499,000 | +5.9% | 8,568 | +9.2% | 0.12% | -5.3% |
| Q3 2021 | $471,000 | +11.3% | 7,846 | +11.1% | 0.13% | +13.8% |
| Q2 2021 | $423,000 | +59.6% | 7,065 | +32.4% | 0.12% | +50.6% |
| Q1 2021 | $265,000 | -33.4% | 5,335 | -33.0% | 0.08% | -36.9% |
| Q4 2020 | $398,000 | +7.6% | 7,957 | +18.0% | 0.12% | -12.2% |
| Q3 2020 | $370,000 | +13.5% | 6,744 | +9.3% | 0.14% | +27.5% |
| Q2 2020 | $326,000 | -30.8% | 6,168 | -34.7% | 0.11% | -31.9% |
| Q4 2019 | $471,000 | – | 9,444 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |